Press release from Companies
Published: 2025-10-17 09:02:59
Bio-Works Technologies AB today announces that the company has received an order from a returning customer in Europe for 69 liters of WorkBeads™ affimAb, valued at approximately SEK 8.3 million. Deliveries are scheduled for the first and second quarters of 2026.
The order confirms continued trust from the customer and underscores Bio-Works’ strong position as a supplier of high-quality chromatography products to the biotechnology and biopharmaceutical industries.
"Receiving this repeat order from an established customer is clear proof that our products deliver on quality and performance. We are proud to continue contributing to our customers’ success in the development and production of biological drugs," says Lone Poulsen Carlbom, CEO of Bio-Works.
WorkBeads™ affimAb is a chromatography medium developed for the purification of monoclonal antibodies (mAbs) and other protein-based drugs, where high affinity and robust performance are critical.
Contact
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Lone Carlbom, CEO, email: lone.carlbom@bio-works.com (lone.carlbom@bio-works.com), phone: +46(0)8-502 705 84.
About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.
Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.
